SureTrader Nadex Advertisement
Home > Boards > US Listed > Medical - Drugs >

Palatin Technologies Inc. (PTN)

PTN RSS Feed
Add PTN Price Alert      Hide Sticky   Hide Intro
Moderator: Olde English 800, chemist72, oleskool56, seasonedwell
Search This Board: 
Last Post: 2/24/2017 10:57:19 AM - Followers: 161 - Board type: Free - Posts Today: 0

http://www.palatin.com/

http://finance.yahoo.com/q/ks?s=PTN+Key+Statistics

Palatin Technologies, Inc., a biopharmaceutical company, develops peptide, peptide mimetic, and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems in the United States. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist for the treatment of sexual dysfunction, targeting female sexual dysfunction and erectile dysfunction in patients non-responsive to current therapies; peptide and small molecule melanocortin receptor agonists for treatment of female sexual dysfunction, erectile dysfunction, and other indications; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist for the treatment of acute exacerbations of asthma and heart failure. The company has research collaboration and license agreement with AstraZeneca AB to commercialize compounds that target melanocortin receptors for the treatment of obesity, diabetes, and related metabolic syndrome. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PTN
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PTN News: Amended Statement of Ownership (sc 13g/a) 02/14/2017 09:01:47 AM
PTN News: Quarterly Report (10-q) 02/10/2017 04:21:21 PM
PTN News: Amended Statement of Ownership (sc 13g/a) 02/09/2017 04:24:39 PM
PTN News: Current Report Filing (8-k) 02/09/2017 08:33:51 AM
PTN News: Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2017 Results; Teleconference and Webcast to be held on February... 02/09/2017 07:30:00 AM
PostSubject
#2395  Sticky Note Warrant info from latest 10-Q: chemist72 02/14/17 12:46:11 PM
#2419   PTN: .3551 - another new all-time low; chemist72 02/24/17 10:57:19 AM
#2418   Warrant holders know they can keep driving the chemist72 02/24/17 09:30:36 AM
#2417   The free/.01 warrants have come home to roost chemist72 02/24/17 09:20:15 AM
#2416   As I have mentioned previously, I'm not looking chemist72 02/23/17 12:57:42 PM
#2415   Indeed. This thing can't stay down forever. Unfortunately, Kyle5 02/23/17 12:42:39 PM
#2414   PTN: .3611 is an all-time low - chemist72 02/23/17 12:30:43 PM
#2413   At this rate we will reach .3 by Kyle5 02/23/17 10:23:00 AM
#2412   PTN: .3626, new 52-week low and afraid we chemist72 02/23/17 10:01:42 AM
#2411   How you liking these shares now?! If RFB 02/23/17 09:48:19 AM
#2410   Met secondary endpoints. stocker25 02/22/17 07:47:16 AM
#2409   After Brem FDA approval the warrants and share stocker25 02/22/17 07:43:22 AM
#2407   Good points RFB. You've offered some practical points gimmeshelter 02/21/17 04:57:01 PM
#2406   Danger, I have zero doubt there is RFB 02/21/17 09:14:38 AM
#2405   Isn't PHRMA ground zero for fat cat CEOs? dangerx 02/17/17 08:12:46 PM
#2404   Best thing that could happen is AMAG buys RFB 02/16/17 09:18:59 AM
#2402   I remember this post from just over a RFB 02/15/17 01:54:12 PM
#2400   For anyone that may read this...do not buy RFB 02/15/17 10:12:20 AM
#2399   Would not disagree with that assessment as it RFB 02/15/17 08:39:38 AM
#2398   This is still a steaming pile of dog shit.. MrPoppaGeorgeo 02/14/17 02:53:47 PM
#2397   I got a whiff of something....it smells like......a RFB 02/14/17 02:50:36 PM
#2396   Short term appears that .39 is the bottom....will RFB 02/14/17 02:05:27 PM
#2395   Warrant info from latest 10-Q: chemist72 02/14/17 12:46:11 PM
#2394   CONVERT > SELL RFB 02/14/17 12:17:11 PM
#2393   As everyone knows by now, I have never RFB 02/14/17 10:24:28 AM
#2392   Would appear based on filing this morning that RFB 02/14/17 10:04:06 AM
#2391   Thought .40 might hold, but some serious action RFB 02/13/17 12:03:56 PM
#2390   Current thinking on a buying strategy for PTN - chemist72 02/13/17 10:41:09 AM
#2389   A quick look at AMAG/PTN License Agreement - chemist72 02/13/17 10:27:46 AM
#2388   LOL....LOL....LMAO....ROFLMAO... You are actually implying that Spana and Wil RFB 02/13/17 10:26:16 AM
#2387   No, he pays himself and all of his RFB 02/13/17 10:07:43 AM
#2386   Instead of using the entire $60M upfront payment chemist72 02/13/17 10:07:39 AM
#2385   With Spana and others getting "rewarded" with stock NavyHusker 02/13/17 09:53:56 AM
#2384   I will add, this does not address all RFB 02/13/17 09:45:11 AM
#2383   But as we approach the NDA filing, the gimmeshelter 02/13/17 03:22:05 AM
#2382   Thanks for this chemist, nice work. Kyle5 02/12/17 09:48:00 AM
#2381   PTN Warrant FACTS from latest 10-Q: chemist72 02/11/17 04:48:56 PM
#2380   I like making money so a stock like 1syndicate 02/10/17 05:37:09 PM
#2379   RPK does have valid points... Danl 02/10/17 05:00:24 PM
#2377   What folks here can not wrap their brains RFB 02/10/17 10:42:09 AM
#2376   What's so HORRIBLE about deal with AMAG?? chemist72 02/10/17 10:28:49 AM
#2375   irdirect.net/filings/viewer/index/911216/000119312517036158/ 13d- Theo 02/09/17 05:54:13 PM
#2374   Not according to plan Olde English 800 02/09/17 01:11:02 PM
#2373   Here we go. pre-market trading!! Spikedog 02/09/17 08:24:32 AM
#2372   Yes PTN is looking good through 2018. Could Spikedog 02/09/17 08:13:56 AM
#2371   http://ih.advfn.com/p.php?pid=nmona&article=73812206 Spikedog 02/09/17 07:45:37 AM
#2370   http://www.prnewswire.com/news-releases/palatin-technologies-inc-reports-second- rrojarom 02/09/17 07:44:24 AM
#2369   PTN to announce earnings tomorrow before the market Olde English 800 02/08/17 03:56:31 PM
#2368   Fair enough. Should have said no sales rather dangerx 02/07/17 02:53:17 PM
#2367   My glasses may be half-green instead of half-empty gimmeshelter 02/06/17 02:31:12 PM
#2366   "working with no revenue for over a decade" RFB 02/06/17 02:08:08 PM
PostSubject